Juan Domínguez-Herrera

1.2k total citations
22 papers, 958 citations indexed

About

Juan Domínguez-Herrera is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Juan Domínguez-Herrera has authored 22 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Medicine, 10 papers in Pharmacology and 8 papers in Epidemiology. Recurrent topics in Juan Domínguez-Herrera's work include Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Vibrio bacteria research studies (5 papers). Juan Domínguez-Herrera is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Vibrio bacteria research studies (5 papers). Juan Domínguez-Herrera collaborates with scholars based in Spain, France and United States. Juan Domínguez-Herrera's co-authors include Jerónimo Pachón, Younes Smani, Rafael López-Rojas, Fernando Docobo-Pérez, Michael J. McConnell, Jiménez-Mejías Me, C. Pichardo, Álvaro Pascual, Luís Rivas and María Fernández‐Reyes and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Juan Domínguez-Herrera

22 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Domínguez-Herrera Spain	16	749	290	274	271	213	22	958
Christi L. McElheny United States	19	854 1.1×	283 1.0×	224 0.8×	274 1.0×	303 1.4×	46	1.0k
Bjørg Haldorsen Norway	19	788 1.1×	399 1.4×	237 0.9×	135 0.5×	186 0.9×	31	1.1k
Floriana Gona Italy	15	607 0.8×	298 1.0×	237 0.9×	165 0.6×	214 1.0×	28	976
Felipe Fernández-Cuenca Spain	18	550 0.7×	232 0.8×	314 1.1×	122 0.5×	104 0.5×	56	871
Di Lin China	4	701 0.9×	274 0.9×	193 0.7×	135 0.5×	197 0.9×	6	798
Ahmed Hamouda United Kingdom	16	809 1.1×	426 1.5×	313 1.1×	181 0.7×	133 0.6×	35	968
Zackery P. Bulman United States	19	700 0.9×	159 0.5×	216 0.8×	469 1.7×	264 1.2×	50	993
Mohamed Abd El-Gawad El-Sayed Ahmed Egypt	12	638 0.9×	198 0.7×	224 0.8×	165 0.6×	100 0.5×	19	858
Lingbin Shu China	14	1.2k 1.6×	461 1.6×	307 1.1×	240 0.9×	264 1.2×	18	1.3k
Diego Faccone Argentina	20	624 0.8×	334 1.2×	246 0.9×	123 0.5×	215 1.0×	64	1.1k

Countries citing papers authored by Juan Domínguez-Herrera

Since Specialization

Citations

This map shows the geographic impact of Juan Domínguez-Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Domínguez-Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Domínguez-Herrera more than expected).

Fields of papers citing papers by Juan Domínguez-Herrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Domínguez-Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Domínguez-Herrera. The network helps show where Juan Domínguez-Herrera may publish in the future.

Co-authorship network of co-authors of Juan Domínguez-Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Domínguez-Herrera. A scholar is included among the top collaborators of Juan Domínguez-Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Domínguez-Herrera. Juan Domínguez-Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Me, Jiménez-Mejías, Rafael Ayerbe-Algaba, Juan Domínguez-Herrera, et al.. (2022). Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(1). 14–21. 4 indexed citations

Me, Jiménez-Mejías, Rafael Ayerbe-Algaba, Juan Domínguez-Herrera, et al.. (2020). Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy. Enfermedades Infecciosas y Microbiología Clínica. 40(1). 14–21. 4 indexed citations

Domínguez-Herrera, Juan, et al.. (2016). Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis. International Journal of Antimicrobial Agents. 48(6). 661–665. 10 indexed citations

Smani, Younes, et al.. (2015). Therapeutic Efficacy of Lysophosphatidylcholine in Severe Infections Caused by Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 59(7). 3920–3924. 39 indexed citations

Smani, Younes, Juan Domínguez-Herrera, & Jerónimo Pachón. (2013). Association of the Outer Membrane Protein Omp33 With Fitness and Virulence of Acinetobacter baumannii. The Journal of Infectious Diseases. 208(10). 1561–1570. 107 indexed citations

Docobo-Pérez, Fernando, Lorena López‐Cerero, Rafael López-Rojas, et al.. (2013). Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis Model. Antimicrobial Agents and Chemotherapy. 57(5). 2109–2113. 52 indexed citations

Martín-Peña, Reyes, Juan Domínguez-Herrera, Jerónimo Pachón, & Michael J. McConnell. (2013). Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCR. Journal of Antimicrobial Chemotherapy. 68(7). 1572–1575. 17 indexed citations

Lepe, José Antonio, Juan Domínguez-Herrera, Jerónimo Pachón, & Javier Aznar. (2013). Determining accurate vancomycin MIC values for methicillin-resistant Staphylococcus aureus by the microdilution method. Journal of Antimicrobial Chemotherapy. 69(1). 136–138. 15 indexed citations

López-Rojas, Rafael, Michael J. McConnell, Jiménez-Mejías Me, et al.. (2013). Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness. Antimicrobial Agents and Chemotherapy. 57(9). 4587–4589. 77 indexed citations

10.

Domínguez-Herrera, Juan, C. Velasco, Fernando Docobo-Pérez, et al.. (2013). Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu. Journal of Antimicrobial Chemotherapy. 68(7). 1609–1615. 27 indexed citations

11.

Smani, Younes, et al.. (2012). Platelet-activating Factor Receptor Initiates Contact of Acinetobacter baumannii Expressing Phosphorylcholine with Host Cells. Journal of Biological Chemistry. 287(32). 26901–26910. 51 indexed citations

12.

Docobo-Pérez, Fernando, Rafael López-Rojas, Juan Domínguez-Herrera, et al.. (2012). Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 67(8). 1961–1967. 24 indexed citations

13.

Smani, Younes, Juan Domínguez-Herrera, & Jerónimo Pachón. (2011). Rifampin Protects Human Lung Epithelial Cells Against Cytotoxicity Induced by Clinical Multi and Pandrug-resistant Acinetobacter baumannii. The Journal of Infectious Diseases. 203(8). 1110–1119. 25 indexed citations

14.

Smani, Younes, Rafael López-Rojas, Juan Domínguez-Herrera, et al.. (2011). In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. Clinical Microbiology and Infection. 18(1). E1–E4. 24 indexed citations

15.

López-Rojas, Rafael, Javier Sánchez‐Céspedes, Fernando Docobo-Pérez, et al.. (2011). Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin. International Journal of Antimicrobial Agents. 38(4). 355–359. 10 indexed citations

16.

Docobo-Pérez, Fernando, Patrice Nordmann, Juan Domínguez-Herrera, et al.. (2011). Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. International Journal of Antimicrobial Agents. 39(3). 251–254. 43 indexed citations

17.

López-Rojas, Rafael, Juan Domínguez-Herrera, Michael J. McConnell, et al.. (2011). Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii. The Journal of Infectious Diseases. 203(4). 545–548. 114 indexed citations

18.

Briales, A., José Manuel Rodríguez-Martínez, C. Velasco, et al.. (2010). In Vitro Effect of qnrA1 , qnrB1 , and qnrS1 Genes on Fluoroquinolone Activity against Isogenic Escherichia coli Isolates with Mutations in gyrA and parC. Antimicrobial Agents and Chemotherapy. 55(3). 1266–1269. 52 indexed citations

19.

Pachón-Ibáñez, María Eugenia, Fernando Docobo-Pérez, Rafael López-Rojas, et al.. (2010). Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 54(3). 1165–1172. 104 indexed citations

20.

Beceiro, Alejandro, Rafael López-Rojas, Juan Domínguez-Herrera, et al.. (2009). In Vitro Activity and In Vivo Efficacy of Clavulanic Acid against Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 53(10). 4298–4304. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact